Articles From: Synopsys Virtual Prototyping Book Achieves Milestone of More Than 3000 Copies in Distribution to Over 1000 Companies to Synthesis Energy Systems Announces New Advanced Higher Pressure Gasification System for Syngas Generation


Synopsys DRC and LVS Signoff Has Speed and Capacity to Handle Huge Flexible Screen Devices MOUNTAIN VIEW, Calif.
Sign-up for Synopsys' IC Validator Adopted by Plastic Logic for Physical Verification of Advanced Displays investment picks
2014/12/8
Top Semiconductor Companies Quickly Adopting IC Compiler II to Tapeout Across Range of Technology Nodes MOUNTAIN VIEW, Calif.
Sign-up for Synopsys' Latest Release of IC Compiler II Ready for Broad Availability of the Power of 10X investment picks
Integrated IP Subsystem, Including ARC EM DSP Processors, Floating Point Unit and Control Peripherals, Improves Performance, Energy Consumption and Design Flexibility MOUNTAIN VIEW, Calif.
Sign-up for Synopsys' New DesignWare Sensor and Control IP Subsystem Delivers Ultra Low Power Sensor and Control Processing for SoCs investment picks
Native SystemVerilog-based Memory VIP Portfolio Expanded to Support JEDEC LPDDR4 with Built-in Coverage, Verification Plan and Protocol-aware Debug MOUNTAIN VIEW, Calif.
Sign-up for Synopsys' New LPDDR4 Verification IP Accelerates Verification Closure for High-Performance Low Power Designs investment picks
Industry-First Solution Includes DesignWare USB 3.1 Controller, IP Virtual Development Kit and Verification IP MOUNTAIN VIEW, Calif.
Sign-up for Synopsys' New USB 3.1 IP Solution Enables 10 Gbps Data Transfer Speeds for Storage, Digital Office and Mobile Applications investment picks
Adopted by More than 70 Semiconductor Companies with Over 50 Tapeouts in First 9 Months MOUNTAIN VIEW, Calif.
Sign-up for Synopsys' PrimeTime ADV Achieves Rapid Adoption for Fastest Timing Closure investment picks
2014/12/3
Synovus Financial Corp.
Sign-up for Synovus Announces Common Stock Dividend investment picks
2015/1/2
Synovus today announced that its Board of Directors has declared a dividend of $0.4921875 per share on the company’s Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series C.
Sign-up for Synovus Announces Quarterly Stock Dividend for Synovus’ Series C Preferred Stock investment picks
2015/1/16
Synovus Chairman and CEO Kessel Stelling will participate in a CEO Perspectives panel discussion during the 2015 Operation HOPE Global Forum scheduled for January 15-17 in Atlanta.
Sign-up for Synovus CEO Joins Operation HOPE Panel investment picks
2015/1/5
Synovus has won two Gold Midas Awards, one Silver Midas Award, and one Midas Certificate for its “Bank of Here” campaign.
Sign-up for Synovus Recognized for “Bank of Here” Campaign investment picks
Synovus Financial Corp.
Sign-up for Synovus to Announce Fourth Quarter 2014 Results on January 27, 2015 investment picks
Synovus Financial Corp.
Sign-up for Synovus to Present at the Bank of America Merrill Lynch Banking & Financial Services Conference investment picks
Synovus Financial Corp.
Sign-up for Synovus to Present at the Bank of America Merrill Lynch Banking & Financial Services Conference investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta Announces FDA’s Oncologic Drugs Advisory Committee to Discuss Pediatric Uses for Ganetespib investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta Announces Initiation of I-SPY 2 TRIAL of Ganetespib in Breast Cancer investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta Announces Presentation on Hsp90 inhibitor Drug Conjugate Platform at 26th EORTC-NCI-AACR Symposium investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta Reports Inducement Grants to New Chief Operating Officer and New Chief Financial Officer investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta Reports Third Quarter Financial Results and Provides Corporate Update investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta Strengthens Management Team with Two Executive Appointments investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta to Host Conference Call and Webcast of Third Quarter 2014 Financial Results on November 6, 2014 investment picks
Synta Pharmaceuticals Corp.
Sign-up for Synta to Present at the Stifel 2014 Healthcare Conference investment picks
TROY, Mich., Oct.
Sign-up for Syntel Announces a Two-for-One Stock Split investment picks
Highlights: Q3 revenue of $228.3M, up 9% from year-ago quarter, and flat sequentially  Q3 EPS of $1.47 per diluted share, up 3% from year-ago quarter, and 4% sequentially Q3 cash & short term investments of $808.7M Global Headcount of 24,333 on September 30, 2014, up 6% from year-ago quarter TROY, Mich., Oct.
Sign-up for Syntel Reports Third Quarter 2014 Financial Results investment picks
2014/10/10
TROY, Mich., Oct.
Sign-up for Syntel to Announce Third Quarter 2014 Results on Thursday, October 16, 2014 investment picks
TROY, Mich., Jan.
Sign-up for Syntel to Present at Investor Conference investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Synopsys Virtual Prototyping Book Achieves Milestone of More Than 3000 Copies in Distribution to Over 1000 Companies to Synthesis Energy Systems Announces New Advanced Higher Pressure Gasification System for Syngas Generation
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent